Addressing Gender Disparities in Secondary Heart Disease Prevention
September 9th 2024Research presented at the 2024 European Society of Cardiology Congress explored gender-based care and outcomes disparities, with potential implications for health care policy and equitable care of women and men in secondary disease prevention.
Read More
Providing Patients a Voice in Their Recovery
September 9th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In this second episode, we speak with Rebekah Sedlock, DSW, LCSW, and Mandy Fauble, PhD, LCSW.
Listen
ChatGPT Outperforms Trainee Doctors in Assessing Pediatric Respiratory Illness
September 9th 2024New findings highlight the potential role of artificial intelligence in supporting health care professionals, but thorough testing is needed before its integration into everyday clinical practice.
Read More
HARMONi-2 Results Could Disrupt the Harmonious NSCLC Treatment Landscape
September 9th 2024The therapeutic landscape for non–small cell lung cancer (NSCLC) has been relatively stable since the 2016 approval of pembrolizumab, but results presented at the 2024 World Conference on Lung Cancer could shake up that status quo.
Read More
New Findings Highlight the Impact of Lung Function Decline in IPF, PPF
September 8th 2024A pair of studies presented at the European Respiratory Society Congress 2024 emphasized the importance of close monitoring and proactive treatment approaches for patients with idiopathic (IPF) and progressive pulmonary fibrosis (PPF).
Read More
Ethical Considerations for AI in Clinical Decision-Making
September 7th 2024Speakers at the European Respiratory Society Congress 2024 highlighted the potential of artificial intelligence (AI) in transforming respiratory health care, while also raising important ethical concerns related to autonomy, equity, transparency, and sustainability.
Read More
Novel Imaging Algorithm Shows Promise in DMD Evaluation
September 6th 2024Measurements on a standard phantom and a clinical data set of patients with Duchenne muscular dystrophy (DMD) were used to validate a novel robust reference frequency method approach, which outperformed typical imaging strategies.
Read More
Tailoring Treatment for Alopecia Areata
September 6th 2024Kristen Whitney, DO, FAAD, determines systemic treatment options for severe alopecia areata based on the patient’s medical history, past treatments tried, potential adverse events, in addition to the weighing risk vs benefit of the therapy and the cost for the patient.
Read More
Dr Sophia Humphreys Discusses GPO Impact on IDN, Hospital Product Decisions
September 5th 2024Sophia Humphreys, PharmD, director of formulary management at Sutter Health, discusses how group purchasing organizations (GPOs) influence integrated delivery networks (IDNs) and hospitals in making formulary decisions, including the adoption of biosimilars.
Watch